Cell entry by reoviruses requires a large, transcriptionally active subvirion particle to gain access to the cytoplasm. The features of this particle have been the subject of debate, but three primary candidates-the infectious subvirion particle (ISVP), ISVP*, and core particle forms-that differ in whether putative membrane penetration protein 1 and adhesin 1 remain particle bound have been identified. Experiments with antibody reagents in this study yielded new information about the steps in particle disassembly during cell entry. Monoclonal antibodies specific for the ␦ region of 1 provided evidence for a conformational change in 1 and for release of the ␦ proteolytic fragment from entering particles. Antiserum raised against cores provided evidence for entry-related changes in particle structure and identified entering particles that largely lack the ␦ fragment inside cells. Antibodies specific for 1 showed that it is also largely shed from entering particles. Limited coimmunostaining with markers for late endosomes and lysosomes indicated the particles lacking ␦ and 1 did not localize to those subcellular compartments, and other observations suggested that both the particles and free ␦ were released into the cytoplasm. Essentially equivalent findings were obtained with native ISVPs and highly infectious recoated particles containing wild-type proteins. Poorly infectious recoated particles containing a hyperstable mutant form of 1, however, showed no evidence for the in vitro and intracellular changes in particle structure normally detected by antibodies, and these particles instead accumulated in late endosomes or lysosomes. Recoated particles with hyperstable 1 were also ineffective at mediating erythrocyte lysis in vitro and promoting ␣-sarcin coentry and intoxication of cells in cultures. Based on these and other findings, we propose that ISVP* is a transient intermediate in cell entry which mediates membrane penetration and is then further uncoated in the cytoplasm to yield particles, resembling cores, that largely lack the ␦ fragment of 1.
The entry of animal viruses into host cells is accompanied by proteolytic cleavage, protein conformational changes, and/or protein shedding events that result in partial or complete disassembly of entering particles. One key aspect of disassembly is the conversion of virions, which often have greater stability in the aqueous environments between cells, to particle forms with more hydrophobic surfaces that can interact with a cellular lipid bilayer and mediate the passage of viral components into the cytoplasm. Other key elements include the activation of viral particles or nucleocapsids for genome transcription, translation, and/or targeting to particular subcellular sites. We have been studying the disassembly cascade and cell entry mechanisms used by a group of large nonenveloped viruses, the mammalian orthoreoviruses (reoviruses).
Reoviruses belong to the family Reoviridae, an evolutionarily divergent group of double-stranded RNA viruses whose human-infecting members also include rota-, orbi-, colti-, and seadornaviruses (see references 52 and 68 for general reviews). Reovirus virions are 85 nm wide and comprise a genome enclosed by two concentric, icosahedral protein capsids (25, 48) . The genome, inner-capsid proteins, and outer-capsid protein 2 constitute the core particle (63) , which is competent for genome-dependent synthesis, capping, and export of translatable viral mRNAs (2, 31, 62) . The surface-exposed outer-capsid proteins 2, 1, 3, and 1 affect survival in the environment (24, 49) and mediate adherence to cells and entry into the cytoplasm (3, 13, 15, 16, 33, 35, 38, 43) . The bulk of the outer capsid consists of 200 heterohexameric complexes of putative membrane penetration protein 1 (76 kDa) and its protector protein, 3 (41 kDa) (25, 40) , arranged in a fenestrated Tϭ13 (alevo) net (48) over the Tϭ1 inner capsid (57) . This lattice is substituted at the fivefold vertices by pentameric turrets of the mRNA-capping protein 2 (144 kDa) (20, 28, 45, 57, 72) . At the center of each turret is anchored a trimeric receptor-binding fiber of adhesin 1 (ϳ50 kDa) (16, 18, 30, 64) . The 1 protein is apparently autolytic and cleaves itself into 4-kDa N-terminal fragment 1N and 72-kDa C-terminal fragment 1C (40, 53) .
Stepwise remodeling and/or disassembly of the outer capsid is a feature of cell entry by reoviruses and can be at least partly recapitulated in vitro. Under some conditions, protease treatment of virions yields infectious subvirion particles (ISVPs), which have lost 3 to degradation and contain a cleaved form of 1 (59-kDa N-terminal fragment ␦ and 13-kDa C-terminal fragment generated from 1C) as the major surface protein (7, 22, 25, 36, 51, 57, 59) . Under other conditions, protease treatment of virions yields cores, which have additionally lost the 1 fragments and 1 (25, 36, 42, 51, 53, 57, 63) . ISVP-like particles are a required intermediate for cell entry (1, 46, 65) and are generated from virions either by extracellular proteolysis in the intestinal lumen (4, 6) or by endosomal or lysosomal proteolysis following endocytic uptake from the cell surface (1, 26, 65) . The capacity of ISVPs, but not virions or cores, to induce membrane permeabilization both in vitro and in cell cultures (8, 13-15, 35, 43, 67) has been interpreted as evidence that ISVP-like particles initiate membrane penetration, resulting in cytoplasmic delivery of "transcriptase particles" activated to synthesize viral mRNAs for translation and packaging. However, ISVPs have hydrophilic surfaces (7, 25, 30, 36) , suggesting they must undergo further changes before insertion into a lipid bilayer. Furthermore, because the viral transcriptases are inhibited in virions and ISVPs but activated in cores (7, 9, 23, 27, 36, 73) , entry must be accompanied or followed by structural changes that result in transcriptase activation. Transcriptase particles derived from infecting virions or ISVPs have been isolated from cells by several groups but have been variously reported to resemble ISVPs or cores in protein composition (e.g., to contain or lack, respectively, large amounts of the 1 fragments) (8, 9, 60, 61) .
In an attempt to understand the membrane penetration step in cell entry by reoviruses, Chandran et al. recently examined the mechanism by which ISVPs induce the permeabilization of erythrocyte membranes (hemolysis) in vitro (13) . They found that hemolysis is preceded by a suite of structural changes in the ISVP, including a conformational change in 1 that exposes hydrophobic regions and increases the sensitivity of the ␦ fragment to further proteolysis. The structural changes also include the shedding of 1 and an inferred conformational change in 2 that promotes 1 release. In sum, these changes convert the ISVP to a distinct particle form, the ISVP*, which is both necessary and sufficient to mediate hemolysis and is activated for viral mRNA synthesis. These results led to the proposal that the ISVP3ISVP* transition must precede membrane penetration and transcriptase activation in cells and that ISVP*s, rather than ISVPs or cores, may most closely resemble the particles that penetrate the cytoplasm and initiate mRNA synthesis (13) .
In the present study, we used a combination of approaches to test whether the ISVP3ISVP* transition must indeed accompany productive cell entry by reoviruses. We found that a conformational change involving the ␦ region of 1 precedes viral protein synthesis in ISVP-infected cells and that 1 is shed from the particles during entry, as predicted by the previous in vitro work. We also found that particles resembling cores are efficiently generated inside cells by the additional shedding of the ␦ proteolytic fragment and that both these particles and free ␦ localize to the cytoplasm early after infection. Recoated particles containing a mutant, hyperstable form of 1 were found to be defective in both the ISVP3ISVP* change in vitro and infection of cells in cultures. Results obtained with recoated particles furthermore established a strong link between productive cell entry and the 1 conformational change and disassembly events discovered in this and previous work. We conclude that the ISVP* is a necessary but transient intermediate in the disassembly cascade that accompanies cell entry by reoviruses.
MATERIALS AND METHODS
Cells. Spinner-adapted L929 cells were grown in Joklik's modified minimal essential medium (Irvine Scientific, Irvine, Calif.) supplemented to contain 2% fetal and 2% calf bovine sera (HyClone, Logan, Utah) as well as 2 mM glutamine, 100 U of penicillin/ml, and 100 g of streptomycin/ml (Irvine Scientific). Mv1Lu and CV-1 cells were grown in Dulbecco's modified Eagle's medium (DMEM) (Invitrogen, Carlsbad, Calif.) supplemented to contain 10% fetal bovine serum, 100 U of penicillin/ml, and 100 g of streptomycin/ml. Sf21 and Tn High Five cells (Invitrogen) were grown in TC-100 medium (Invitrogen) supplemented to contain 10% heat-inactivated fetal bovine serum.
Virions, ISVPs, ISVP*s, and cores. Virions of reovirus T1L were grown and purified by the standard protocol (30) and stored in virion buffer (150 mM NaCl, 10 mM MgCl 2 , 10 mM Tris [pH 7.5]). To generate virions containing [
35 S]methionine-cysteine-labeled proteins, Tran 35 S label (7 mCi) (ICN, Costa Mesa, Calif.) was added at the onset of infection. Nonpurified ISVPs were used in all experiments and were obtained by digesting virions in virion buffer at concentrations of 5 ϫ 10 12 to 1 ϫ 10 13 particles/ml with N␣-p-tosyl-L-lysine chloromethyl ketone-treated ␣-chymotrypsin (200 g/ml) (Sigma-Aldrich, St. Louis. Mo.) for 10 to 20 min at 32 or 37°C. Digestion was stopped by the addition of ethanolic phenylmethylsulfonyl fluoride (2 to 5 mM) (Sigma-Aldrich) at 4°C. Parallel ISVP and ISVP* samples (see Fig. 1 and 2) were obtained by treatment of nonpurified ISVPs at a concentration of 4 ϫ 10 12 particles/ml with NaCl and CsCl (300 mM), respectively, for 10 to 20 min at 32 or 37°C, followed by removal to 4°C. Purified cores were obtained from virions as described previously (15, 54) . Particle concentrations were estimated by measuring the A 260 (22) . Infection of L929 cells and plaque assays to determine viral titers were carried out as described previously (30, 49) .
Antibodies. Monoclonal antibodies (MAbs) specific for reovirus outer-capsid proteins 1 (10H2, 8H6, 4A3, and 10F6), 1 (5C6), and 2 (7F4) were grown and purified as described previously (70) . Human LAMP-2-specific MAb H4B4 (44) was purchased from the Developmental Studies Hybridoma Bank (Department of Biological Sciences, University of Iowa, Iowa City). Human LAMP-1-specific rabbit polyclonal antiserum (11) was a generous gift from M. Fukuda (The Burnham Institute, La Jolla, Calif.). The production of NS-specific rabbit polyclonal antiserum has been described elsewhere (10) . Core-and 1-specific rabbit polyclonal antisera were produced by the Polyclonal Antibody Service (Animal Care Unit, University of Wisconsin Medical School, Madison) from purified T1L cores that had been heat inactivated by incubation for 10 min at 70°C (15) and from purified glutathione S-transferase-T1L 1 fusion protein (13) , respectively. In some cases, primary antibodies were directly conjugated to Alexa 488 (Molecular Probes, Eugene, Oreg.) in accordance with the manufacturer's instructions. All primary antibodies were titrated to maximize the signalto-noise ratio. Goat anti-mouse immunoglobulin G (IgG) and goat anti-rabbit IgG conjugated to Alexa 488 or Alexa 594 were obtained from Molecular Probes and used at a dilution of 1:500.
Plasmid constructs encoding protein 1-HS. Plasmid pBKS-M2L encoding T1L 1 with the P344L and L359F mutations (15) was the template for sitedirected mutagenesis by the QuikChange protocol (Stratagene, La Jolla, Calif.). Complementary mutagenic primers with the sequences 5Ј-GCCATTCCACCTA AGCCAGAAGACTATAATGTGCGTAC-3Ј and 5Ј-GTACGCACATTATAG TCTTCTGGCTTAGGTGGAATGGC-3Ј (nucleotide changes underlined) were used to change alanine 319 to glutamic acid (A319E) and to create a BbsI site for screening mutant clones. A Bsu36I-MluI restriction fragment encoding the desired amino acid changes (A319E, P344L, and L359F) was sequenced and subcloned into shuttle plasmid pFastbacDUAL-M2L-S4L (15) for recombinant baculovirus production (see below). The construct expressing 1 with the A319E, P344L, and L359F mutations is henceforth referred to as 1-HS.
Recombinant 1, 3, and 1. A recombinant baculovirus coexpressing T1L 1-HS and 3 was generated in Sf21 cells by using the Bac-to-Bac system (Invitrogen) as previously described for T1L with wild-type 1 (1-WT) and 3 (15) . A recombinant baculovirus separately expressing T1L 1 has been described elsewhere (17) . Tn High Five cells were infected with third-or fourthpassage baculovirus stocks (5 to 10 PFU/cell) and harvested at 65 h postinfection (p.i.). Cytoplasmic lysates of baculovirus-infected cells expressing only 1 and 3 or expressing 1, 3, and 1 were prepared by lysis with Triton X-100 or probe sonication, respectively, as described previously (15, 16) .
Recoated cores. Recoated cores containing recombinant 1 and 3 (r-cores) or 1, 3, and 1 (r-coresϩ1) were prepared by incubation of insect cell lysates containing these proteins (see above) with purified T1L cores, followed by repurification of particles on CsCl gradients as described previously (15, 16) . Nonpurified ISVP-like and ISVP*-like particles derived from r-cores and r-coresϩ1 (pr-cores and pr-coresϩ1, respectively) were obtained as described above for virions.
Immunoprecipitation. Protein A-conjugated magnetic beads (10 l) (Dynal, Lake Success, N.Y.) were incubated with antibody (15 g of MAb or 35 l of antiserum) for 2 h at room temperature and washed three times with immunoprecipitation buffer (IP buffer) (10 mM Tris [pH 8.0], 150 mM NaCl, 1% NP-40). Viral particles (5 ϫ 10 10 per 10 l) were added to the antibody-bound beads with ice-cold IP buffer (180 l). Samples were incubated with rotary mixing for 1 h at 4°C, washed six times with ice-cold IP buffer, and boiled in gel sample buffer (30) for 3 to 5 min. Proteins released from the beads were detected by liquid scintillation counting or sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) followed by staining with Coomassie brilliant blue R-250 (Sigma-Aldrich) or phosphorimaging with a Storm system (Molecular Dynamics, Sunnyvale, Calif.). ISVP-infected Mv1Lu cells were lysed by incubation with ice-cold IP buffer for 30 min at 4°C in the presence of protease inhibitors (Roche, Indianapolis, Ind.) and centrifuged at 8,000 ϫ g for 10 min to remove nuclei and cell debris (see Fig. 4 ). Viral particles and proteins within the resulting cytoplasmic lysates were immunoprecipitated essentially as described above, except that 20 l of antibody-bound beads was used per reaction with a cytoplasmic lysate generated from ϳ2 ϫ 10 6 cells. Immunostaining and immunofluorescence (IF) microscopy. Mv1Lu or CV-1 cells (2 ϫ 10 5 ) were seeded on the day before infection in six-well plates containing 18-mm round glass coverslips. In most experiments, cells were preincubated with cycloheximide (CHX) (100 g/ml) (Sigma-Aldrich) in DMEM for 1 h at 37°C to block protein synthesis. Nonpurified T1L ISVPs suspended in phosphate-buffered saline (PBS) supplemented with 2 mM MgCl 2 (PBS-MC) (ϳ2.5 ϫ 10 4 particles/cell, unless otherwise noted) were allowed to bind to cells on coverslips for 1 h at 4°C. Coverslips were then rinsed in PBS-MC and fixed immediately or placed in DMEM containing CHX and returned to 37°C. Infected cells were fixed by incubation with 2% paraformaldehyde for 10 to 15 min at room temperature and washed three times with PBS. Fixed cells were permeabilized by incubation with saponin (0.5%) in PBS supplemented with 0.5% bovine serum albumin (PBSA) for immunostaining of LAMP-1 or LAMP-2 or with Triton X-100 (0.1%) in PBSA for immunostaining of viral proteins. Permeabilized cells were incubated with primary antibodies for 30 min in PBSA, washed three times with PBS, and incubated with secondary antibodies for 30 min in PBSA. After three more washes with PBS, coverslips were mounted on glass slides with Prolong antifade reagent (Molecular Probes) and examined by using a TE-300 inverted microscope with fluorescence optics (Nikon, Melville, N.Y.). Wide-field epifluorescence images were collected as described previously (55) and prepared for presentation by using Adobe Photoshop and Illustrator (Adobe Systems, San Jose, Calif.). Confocal images were acquired with an Axiovert 200M inverted microscope (Carl Zeiss, Inc., Thornwood, N.Y.) under the control of SlideBook (Intelligent Imaging Innovations, Denver, Colo.). The microscope was equipped with a motorized filter turret and lens holder, a ϫ63 lens (Pan Apochromat, 1.4 NA; Carl Zeiss), and a spinning-disk confocal head (Perkin-Elmer, Wellesley, Mass.). Three-dimensional image stacks were recorded by acquisition of sequential sections recorded along the z axis by varying the position of the objective lens holder (step size, 0.3 m). Images were processed with SlideBook (two-dimensional maximum-intensity projections). Prior to quantitation, images were deconvolved with the Near-Neighbors algorithm (SlideBook) by using calculated point spread functions (39) .
Flow cytometry. Untreated or CHX-pretreated Mv1Lu cells were suspended in PBS-MC at 2 ϫ 10 7 cells/ml and incubated with ISVPs (ϳ5 ϫ 10 4 particles/cell, unless otherwise noted) for 1 h at 4°C. After being washed with PBS to remove unbound virus, cells were suspended at a concentration of 10 6 /ml in DMEM containing CHX and returned to 37°C. Samples were agitated every 10 to 15 min to keep cells in suspension and were removed to ice at various times. Infected cells were pelleted at 500 ϫ g to remove growth medium and fixed, permeabilized, and immunostained in suspension as described above for cell monolayers. Immunostained cells were suspended in PBS, and data were collected with a FACScalibur flow cytometer and analyzed with CellQuest software (Beckton Dickinson, San Jose, Calif.). Isotype or preimmune serum controls were used to determine background fluorescence with each antibody.
␣-Sarcin coentry assay. The methods of Liprandi and colleagues (41) were used to measure virus-induced intoxication of cells by ␣-sarcin, but with several changes. Confluent L929 cell monolayers in 48-well microplates were preincubated in methionine-free DMEM (Invitrogen) for 2 h at 37°C and washed with ice-cold PBS-MC. Viral particles (ISVPs, ϳ5.0 ϫ 10 4 particles/cell; pr-coresϩ1, ϳ5.0 ϫ 10 5 particles/cell) were allowed to bind to cells for 1 h at 4°C. After two washes with ice-cold PBS-MC to remove unbound virus, prewarmed methioninefree DMEM supplemented with [ 35 S]methionine-cysteine (22 Ci/ml) (Dupont NEN, Wilmington, Del.) and ␣-sarcin (50 g/ml) (Sigma-Aldrich) was added.
After incubation for various times at 37°C, cells were lysed and proteins were precipitated with ice-cold trichloroacetic acid (10%) for 1 h. Precipitates were washed with acetone, air dried, and solubilized with 1% SDS in 0.1 M NaOH. Acid-precipitable counts were measured by liquid scintillation counting to quantitate the incorporation of 35 S-labeled amino acids into proteins. SDS-PAGE and immunoblotting. SDS-PAGE was performed with 10% acrylamide gels as described previously (51) . Viral proteins were detected with Coomassie brilliant blue R-250. Gels loaded with radiolabeled proteins were dried on filter paper and visualized by phosphorimaging with the Storm system. For immunoblotting, proteins were transferred to nitrocellulose with a Mini-TransBlot system (Bio-Rad, Hercules, Calif.). 1-specific mouse MAb 10F6 (1:1,000 dilution) and mouse-specific goat IgG conjugated to alkaline phosphatase (1: 2,000 dilution) (Sigma-Aldrich) were used as primary and secondary antibodies, respectively. Antibody binding was detected with colorimetric reagents p-nitroblue tetrazolium chloride and 5-bromo-4-chloro-3-indolylphosphate p-toluidine salt (Bio-Rad).
RESULTS
MAbs 4A3 and 10F6 detect the 1 conformational change in vitro and at early times p.i. To further explore the conformational change in 1 that accompanies the ISVP3ISVP* transition, we assessed the capacity of four MAbs specific for the ␦ region of 1 (70) to immunoprecipitate purified T1L ISVPs or ISVP*s in vitro. MAbs 10H2 and 8H6 precipitated similar numbers of ISVPs and ISVP*s, suggesting that their epitopes are similarly exposed and accessible in both particles (Fig. 1a) . In contrast, MAbs 4A3 and 10F6 precipitated much smaller numbers of ISVPs than of ISVP*s (only 1 in 100 to 1 in 50 as many) (Fig. 1a) , suggesting that their epitopes are accessible in ISVP*s but masked in ISVPs.
The capacity of MAbs 4A3 and 10F6 to recognize the ␦ region of 1 in ISVP*s but not in ISVPs in vitro led us to hypothesize that they may be useful for detecting the 1 conformational change during cell entry. To test this hypothesis, we allowed T1L ISVPs to adsorb to Mv1Lu cells at 4°C and later immunostained the samples with 10H2, 8H6, 4A3, or 10F6 ( Fig. 1b to e ). Before adsorption, we treated the cells with CHX to abolish protein synthesis and to ensure that only proteins in infecting particles were later detected by IF microscopy. When cells kept at 4°C after adsorption were stained with 10H2 (Fig. 1b) or 8H6 (Fig. 1c) , we observed punctate staining concentrated at cell margins, suggesting that the MAbs were bound to ISVPs at the cell surface. We obtained similar results with 1-specific MAb 5C6 (70) (data not shown). In contrast, we observed little staining with 4A3 ( Fig. 1d) or 10F6 (Fig. 1e) . These findings are consistent with the immunoprecipitation results ( Fig. 1a) and provide further evidence that 10H2 and 8H6 recognize the 1 conformer in ISVPs, whereas 4A3 and 10F6 do so only poorly.
When ISVP-adsorbed cells were warmed to 37°C and immunostained with 10H2 (Fig. 1b) or 8H6 (Fig. 1c ) at 2 h p.i., punctate staining was still observed, suggesting that the MAbs were bound to the ␦ region of 1 in viral particles before or after uptake from the cell surface. Interestingly, some diffuse cytoplasmic and nuclear staining also was seen in many cells. More striking was the dramatic induction of staining by 4A3 (Fig. 1d) or 10F6 (Fig. 1e ) at 2 h p.i. This staining was largely diffuse and distributed throughout the cytoplasm and nucleus, although some punctate staining also was noted. We conclude from these results that 1 changes conformation at early times p.i., such that a large proportion of its ␦ region can be newly recognized by 4A3 and 10F6. We also conclude that much of
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this conformationally altered protein region is no longer particle bound, since its staining is diffuse and not confined to punctate spots. In addition, the presence of 4A3 and 10F6 staining in the cytoplasm and nucleus strongly suggested that a substantial fraction of the ␦ fragment had successfully penetrated the cellular membrane barrier. Anticore serum detects changes in particle structure in vitro and at early times p.i. In the course of the present experiments, we found that a polyclonal antiserum raised against reovirus cores (15) also differs in its capacity to recognize ISVPs and ISVP*s. This antiserum precipitated similar numbers of ISVP*s and cores but only small numbers of ISVPs in vitro (1 in 50 to 1 in 25 as many ISVPs as ISVP*s or cores) (Fig. 2a) . These findings suggested that core epitopes are largely masked in ISVPs but become more accessible upon changes in particle structure during the ISVP3ISVP* and ISVP*3core transitions. Anticore serum therefore may be another useful reagent 
FIG. 2.
Anticore serum detects changes in particle structure in vitro and within infected cells. (a) 35 S-labeled ISVPs, ISVP*s, and cores were immunoprecipitated with protein A-conjugated magnetic beads alone (none) or beads bound to 2-specific MAb 7F4 (␣-2) or anticore serum (␣-core). Viral particles bound to antibody were quantitated by liquid scintillation counting. Error bars indicate standard deviations. (b) ISVPs were allowed to adsorb to CHX-pretreated Mv1Lu cells at 4°C, and cells were fixed at 0 or 2 h p.i. at 37°C. Cells were permeabilized and immunostained with anticore serum, followed by goat anti-rabbit IgG conjugated to Alexa 594. (c) Cells were infected as described for panel b, fixed at 2 h p.i. at 37°C, permeabilized, and coimmunostained with anticore serum and 7F4, followed by goat anti-mouse IgG conjugated to Alexa 488 and goat anti-rabbit IgG conjugated to Alexa 594. Arrows in panel c insets indicate punctate spots detected by 7F4 but not anticore serum. Bars, 10 m. for detecting changes in particle structure during cell entry. To test this possibility, we allowed T1L ISVPs to adsorb to CHXtreated Mv1Lu cells as described above and later immunostained the samples with anticore serum (Fig. 2b and c) . Little staining was observed in cells kept at 4°C, confirming that anticore serum binds poorly to ISVPs at the cell surface (Fig.  2b) . When the cells were warmed to 37°C and immunostained with anticore serum, however, a dramatic induction of staining was seen. This staining was exclusively punctate in nature (Fig.  2b and c) and colocalized with staining for core protein 2 by 2-specific MAb 7F4 (Fig. 2c) . We conclude that infecting ISVPs undergo changes in particle structure at early times p.i., such that they can be newly recognized by antibodies in anticore serum.
Changes in particle structure, including the 1 conformational change, precede viral protein synthesis. We hypothesized that the structural changes exhibited by ISVPs within 2 h p.i. may be linked to productive cell entry. As a test, we compared the kinetics of changes detected by MAb 4A3 or 10F6 or by anticore serum with those of a marker for productive cell entry, the synthesis of viral nonstructural protein NS. T1L ISVPs were allowed to adsorb to CHX-treated or untreated Mv1Lu cells at 4°C, and cells were prepared for immunostaining either immediately or after incubation at 37°C for various times. Untreated samples were immunostained with anti-NS serum (10) . All samples were then analyzed by flow cytometry. Induction of staining with 4A3, 10F6, or anticore serum in CHX-treated cells occurred rapidly and with similar kinetics (0 to 10 min p.i.) (Fig. 3) , suggesting that the 1 conformational change and particle disassembly are contemporaneous. The induction of NS synthesis in untreated cells lagged the structural changes by ϳ20 min (Fig. 3b) , consistent with the hypothesis that structural changes are associated with penetration of viral particles into the cytoplasm and/or derepression of transcriptase complexes within the particles.
IF microscopy evidence for the release of ␦ and 1 from viral particles during cell entry. To characterize the particles detected by anticore serum at early times p.i. in the absence of protein synthesis, we infected CHX-treated Mv1Lu cells with T1L ISVPs and later immunostained the samples with anticore serum together with MAbs specific for the ␦ region of 1 or 1. At 2 h p.i., we observed colocalization in only a few punctate spots with anticore serum and ␦-specific MAb 10H2 (Fig. 4a) , 4A3 (Fig. 4b) , or 10F6 (data not shown), suggesting that most of the particles recognized by anticore serum contained little ␦. In addition, the punctate staining detected with anticore serum largely did not colocalize with that detected with 1-specific MAb 5C6, suggesting that the particles also contained little 1 (Fig. 4c) . We considered it possible that the particles resembling cores might have been generated by proteolysis of ISVPs or ISVP*s that failed to penetrate the cytoplasm and were instead trapped within hydrolytic compartments of the endocytic pathway. To test this possibility, we coimmunostained ISVP-infected cells with anticore serum and antibodies specific for the late endosomal and lysosomal proteins LAMP-1 and LAMP-2 (11, 44) . At 2 h p.i., little colocalization was observed between the particles and LAMP-1-positive (data not shown) or LAMP-2-positive (Fig. 4d) compartments, leading us to conclude that particles that resemble cores and that are produced during cell entry are not associated with late endosomes or lysosomes and likely are localized to the cytoplasm (see Discussion for other results).
Immunoprecipitation evidence for the release of ␦ and 1 from viral particles during cell entry. We used immunoprecipitation as a further test of whether particles resembling cores are generated from infecting ISVPs at early times p.i. [ 35 S]methionine-cysteine-labeled ISVPs were allowed to adsorb to CHX-treated Mv1Lu cells at 4°C, and the cells were lysed with nonionic detergent either immediately or after incubation at 37°C for 2 h. Postnuclear cell extracts were incubated with anticore serum or 2-specific MAb 7F4, and antibody-protein complexes were affinity purified and analyzed by SDS-PAGE. We found that anticore serum precipitated about 10-fold more particles from the 2-h cell extract than from the 0-h cell extract (Fig. 4e and data not shown) , consistent with its increased immunostaining of cells incubated for 2 h at 37°C relative to those kept at 4°C (Fig. 2b) . A more modest (about jvi.asm.org twofold) increase was observed with 7F4 ( Fig. 4e and data not shown). Densitometric quantitation of core proteins and ␦ (Fig. 4f ) and visual comparison of 1 levels in Fig. 4e further indicated that particles precipitated from the 2-h cell extract by anticore serum or 7F4 contained much less ␦ and 1 than purified ISVPs, whereas particles precipitated from the 0-h cell extract resembled ISVPs in protein composition (Fig. 4f) . These results provide additional evidence that both ␦ and 1 are lost from viral particles during cell entry. ISVP-like particles derived from recoated cores containing mutant 1-HS are defective in hemolysis and do not undergo the ISVP3ISVP* transition at 37°C in vitro. Having observed structural changes that precede viral protein synthesis at early times p.i. with ISVPs, we sought further evidence that these changes are linked to productive cell entry. To this end, we obtained and characterized hyperstable ISVPs that convert to ISVP*s only poorly at physiological temperatures in vitro. Previous work provided clues for engineering such particles. ISVPs derived from ethanol-resistant viral clones containing mutations in 1 (e.g., A319E) and ISVP-like particles derived from recoated cores containing 1 with the P344L and L359F mutations exhibit quantitative defects in in vitro membrane permeabilization (15, 35, 71 ; K. Chandran and M. L. Nibert, unpublished data). Because virus-induced permeabilization of erythrocytes requires ISVP*-like particles (13), we reasoned that these mutations may act by slowing the ISVP3ISVP* transition and may cause a more severe defect if combined in the same protein. Accordingly, we engineered 1-HS together with wild-type 1 and generated recoated cores containing 1-HS or 1-WT [r-cores(1-HS) and r-cores(1-WT), respectively). r-cores(1-HS) resembled r-cores(1-WT) in protein composition (Fig. 5a ), three-dimensional structure determined by scanning electron cryomicroscopy (12) (data not shown), and capacity to convert to ISVP-like particles [prcores(1-HS)] upon chymotrypsin treatment (Fig. 5a ), indicating that the mutations in 1-HS caused no gross defects in viral structure.
We next monitored the capacity of pr-cores(1-WT) and pr-cores(1-HS) to lyse erthyrocytes at 37°C. pr-cores(1-WT) induced hemolysis at concentrations above 10 12 particles per ml, whereas no hemolysis was detected with pr-cores(1-HS), even at 5-to 10-fold-higher concentrations of viral particles (Fig. 5b and data not shown) . Assessment of the conformational status of 1-WT and 1-HS within hemolysis reactions by protease treatment at 4°C confirmed that the onset of hemolysis was temporally correlated with the 131* change, as described previously (13) , and provided evidence that prcores(1-HS) failed to induce hemolysis because they did not undergo the 131* change under the conditions used ( Fig.  5c and d) .
We also used 1-specific MAbs to assess the capacity of pr-cores(1-HS) to undergo the 131* change. pr- WT) and pr-cores(1-HS) to mediate hemolysis, determined as previously described for ISVPs (13) . Washed citrated bovine calf erythrocytes (3% [vol/vol]) were incubated with increasing concentrations of viral particles in virion buffer for 1 h at 37°C, and the extent of hemoglobin release into the supernatant was measured relative to that in controls containing only virion buffer and erythrocytes (0%) or water and erythrocytes (100%). Values from two independent experiments are shown. (c) Kinetics of hemolysis mediated by pr-cores(1-WT) and pr-cores(1-HS). Erythrocytes were incubated with viral particles (4 ϫ 10 12 per ml) for different times at 37°C, and the extent of hemolysis was determined as described for panel b. Values from two independent experiments are shown. (d) Conformational status of protein 1. Aliquots (10 l) from the hemolysis reactions in panel c were incubated with trypsin (100 g/ml) for 30 min at 4°C, digestion was stopped by the addition of soybean trypsin inhibitor (300 g/ml), and viral capsid proteins were resolved by SDS-PAGE. Protein 1 was visualized by immunoblotting with 1-specific MAb 10F6. A portion of each immunoblot containing the region of interest is shown. Positions of viral proteins are indicated at the left. (e and f) Capacities of pr-coresϮ1(1-WT) and pr-coresϮ1(1-HS) to undergo conversion to ISVP*-like particles. pr-cores(1-WT) (e) and pr-cores(1-HS) (f) (4 ϫ 10 12 per ml) were incubated with 300 mM NaCl (Ϫ) or CsCl (ϩ) for 20 min at 37°C to inhibit or promote conversion to ISVP*-like particles, respectively (see the text for details). Viral particles were immunoprecipitated with protein A-conjugated magnetic beads alone (no Ab) or beads bound to 10H2 or 10F6. pr-coresϩ1(1-WT) (e) and pr-coresϩ1(1-HS) (f) were prepared and incubated with NaCl or CsCl as described above and immunoprecipitated with 1-specific MAb 5C6 (␣-1). Viral capsid proteins bound to beads were resolved by SDS-PAGE and visualized by Coomassie brilliant blue R-250 staining. Positions of viral proteins are indicated at the left and right. IgG H, IgG heavy chain; IgG L, IgG light chain; no IP, no immunoprecipitation (see the legend to Fig. 4) . Asterisks indicate positions of protease bands.
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cores(1-WT) and pr-cores(1-HS) were incubated under conditions that favored either the maintenance of ISVPs or the conversion to ISVP*s. Samples were then immunoprecipitated with MAb 10H2 or 10F6 and resolved by SDS-PAGE and Coomassie brilliant blue R-250 staining. pr-cores(1-WT) preincubated with NaCl were recognized by 10H2 but not by 10F6, whereas pr-cores(1-WT) preincubated with CsCl were recognized by both MAbs, consistent with a Cs ϩ -accelerated 131* change in viral particles (13) (Fig. 5e) . pr-cores(1-HS) preincubated with NaCl produced a pattern of MAb recognition similar to that produced by pr-cores(1-WT), providing additional evidence that particle-bound 1-HS resembles 1-WT in overall protein conformation (Fig. 5f) . In contrast to pr-cores(1-WT), however, pr-cores(1-HS) preincubated with CsCl were recognized by 10H2 but not by 10F6, supporting the conclusion that they undergo the 131* change very slowly at 37°C (Fig. 5f) .
In native ISVPs, the 131* change is accompanied by 1 release from particles (13) (Fig. 5f ). To test whether recoated particles containing 1-HS exhibited 1 release even in the absence of a detectable 131* change, we preincubated pr-coresϩ1(1-WT) and pr-coresϩ1(1-HS) with NaCl or CsCl, immunoprecipitated the samples with 1-specific MAb 5C6, and analyzed the precipitated proteins as described above ( Fig. 5e and f) . pr-coresϩ1(1-WT) preincubated with NaCl were precipitated by 5C6, whereas pr-coresϩ1(1-WT) preincubated with CsCl were not, indicating the release of 1 in association with the 131* change, as expected (Fig. 5e) . In contrast, pr-coresϩ1(1-HS) preincubated with either NaCl or CsCl were precipitated by 5C6, indicating that they had not lost 1 and providing further evidence that 1 release from particles requires the 131* change (Fig. 5f) .
pr-cores؉1(1-HS) are defective in cell entry. Because pr-coresϮ1(1-HS) are defective in undergoing the ISVP3ISVP* transition and in mediating membrane permeabilization in vitro, we predicted that they also would be defective in productive cell entry. To test this prediction, we allowed pr-coresϩ1(1-WT) or pr-coresϩ1(1-HS) to adsorb to Mv1Lu cells at 4°C and then fixed and immunostained the cells with anti-NS serum either immediately or after incubation at 37°C for 4 or 8 h. The stained cells were analyzed by flow cytometry to measure viral protein synthesis. A large increase in anti-NS serum staining was seen in cells infected with pr-coresϩ1(1-WT) by 4 h p.i., with an even larger increase by 8 h p.i. (Fig. 6a) . In contrast, only low levels of NS synthesis were apparent by 4 or 8 h p.i. in cells infected with pr-coresϩ1(1-HS) (Fig. 6b) . These results demonstrated that the levels of productive cell entry and/or induction of viral protein synthesis achieved by pr-coresϩ1(1-HS) were much lower than those achieved by pr-coresϩ1(1-WT) at the same times.
To determine whether viral particles containing 1-HS have reduced infectivity, as the protein synthesis findings would infer, we examined the capacities of pr-coresϮ1(1-WT) and pr-coresϮ1(1-HS) to form plaques on L929 cell monolayers. In each case, we normalized the infectivity value to reflect the efficiency of plaque formation on a per-particle basis. prcoresϩ1(1-WT) resembled native ISVPs in relative infectivity, with an enhancement over parent cores in excess of 100,000 (Fig. 6c) . In contrast, pr-coresϩ1(1-HS) were only 0.01 times as infectious as pr-coresϩ1(1-WT) (Fig. 6c) . This difference was also reproducible with r-cores lacking 1 (Fig.  6c) . These findings indicate that viral particles containing 1-HS have greatly reduced infectivity, likely because the mutations in 1 compromise their capacity to mediate productive cell entry.
pr-cores؉1(1-HS) do not undergo the 1 conformational change and conversion to particles resembling cores by 2 h p.i. In an effort to pinpoint the defect of pr-coresϩ1(1-HS) in cell entry, we allowed pr-coresϩ1(1-WT) or prcoresϩ1(1-HS) to adsorb to CHX-treated Mv1Lu cells; later, we immunostained the cells with MAb 10H2 or 10F6 or anticore serum and analyzed the staining patterns by IF microscopy (Fig. 7a to c) or flow cytometry (Fig. 7d and e) . In cells adsorbed to either particle type and then kept at 4°C, we observed a pattern of staining with all three antibodies similar to that in ISVP-adsorbed cells. Specifically, 10H2 showed punctate staining concentrated at cell margins, indicating that both pr-coresϩ1(1-WT) and pr-coresϩ1(1-HS) were bound to Mv1Lu cells and detected by 10H2 at the cell surface (Fig. 7a) . The capacity of both particle types to bind to cells was confirmed by flow cytometric quantitation of cell-associ- ated fluorescence following immunostaining with 10H2 or a virion-specific antiserum ( Fig. 7d and e) . In contrast to 10H2, 10F6 (Fig. 7b, d , and e) and anticore serum (Fig. 7c to e) showed little staining, consistent with the limited capacities of these antibodies to immunoprecipitate pr-coresϩ1(1-WT) and pr-coresϩ1(1-HS) in vitro ( Fig. 5e and f and data not shown for anticore serum). Qualitatively different 10H2 staining patterns between prcoresϩ1(1-WT) and pr-coresϩ1(1-HS) were observed in particle-adsorbed cells warmed to 37°C and fixed at 2 h p.i. In cells infected with pr-coresϩ1(1-WT), 10H2 showed a combination of punctate and diffuse staining (Fig. 7a) resembling that in ISVP-infected cells (Fig. 1b) . In contrast, 10H2 staining in cells infected with pr-coresϩ1(1-HS) was almost entirely punctate and was markedly concentrated in perinuclear regions (Fig. 7a) . Similar punctate staining, concentrated in perinuclear regions, was observed with 1-specific MAb 5C6 as well (data not shown). These findings suggested different intracellular fates for particles containing 1-WT and 1-HS.
To test for the intracellular 1 conformational change, infected cells warmed to 37°C and fixed at 2 h p.i. were immunostained with 10F6. A dramatic induction of 10F6 staining was observed by both IF microscopy ( Fig. 7b) and flow cytometry (Fig. 7d ) in cells infected with pr-coresϩ1(1-WT), indicating that these particles undergo the 1 conformational change shortly after infection, as was also found with ISVPs (Fig. 1e) . In contrast, little increase in 10F6 staining was seen in cells infected with pr-coresϩ1(1-HS), suggesting that the latter particles do not undergo the 1 conformational change to an appreciable degree by 2 h p.i. (Fig. 7b and e) .
In cells infected with pr-coresϩ1(1-WT), 10F6 showed a combination of diffuse and punctate staining (Fig. 7b) , as was also found with ISVPs (Fig. 1e) . The diffuse staining provided evidence for the disassembly of ␦ from particles and suggested that particles resembling cores are generated in cells infected with pr-coresϩ1(1-WT). Two further observations supported that conclusion. First, a large induction in immunostaining with anticore serum was observed by both IF microscopy and flow cytometry ( Fig. 7c and d) . Second, coimmunostaining with 2-specific MAb 7F4 and either 1-specific MAb 10H2 or 1-specific polyclonal antiserum showed many punctate spots containing core protein 2 but neither the ␦ region of 1 (Fig. 8a) nor 1 (data not shown) . In contrast to the results obtained with pr-coresϩ1(1-WT), little induction of immunostaining with anticore serum was seen in cells infected with pr-coresϩ1(1-HS) (Fig. 7c and e) , and few punctate spots containing core proteins but lacking ␦ (Fig. 8b ) or 1 (data not shown) were seen. Taken together, these results provided evidence that few pr-coresϩ1(1-HS) undergo the 1 conformational change or conversion to particles resembling cores by 2 h p.i.
ISVP-like particles accumulate within LAMP-positive endocytic compartments in cells infected with pr-cores؉1(1-HS). The marked concentration of pr-coresϩ1(1-HS) in perinuclear regions (Fig. 7a and 8b ) led us to suspect that these particles are defective in penetrating into the cytoplasm and consequently are trapped within the endocytic pathway. To test this possibility, we infected CHX-pretreated Mv1Lu cells with pr-coresϩ1(1-WT) or pr-coresϩ1(1-HS) for 2 h at 37°C and later coimmunostained the samples with -specific MAb 10H2 and LAMP-1-specific antiserum (11) (Fig. 8c and d) . Confocal microscopy revealed limited colocalization between 10H2 staining and anti-LAMP-1 staining in cells infected with pr-coresϩ1(1-WT) (Fig. 8c) . Much more extensive colocalization of 10H2 staining and anti-LAMP-1 staining was observed in cells infected with pr-coresϩ1(1-HS) (Fig. 8d) [approximately three times the area of colocalization for prcoresϩ1(1-HS) as for pr-coresϩ1(1-WT)]. Furthermore, colocalization of staining for 10H2 and anti-1 serum in perinuclear regions was essentially complete in cells infected with pr-coresϩ1(1-HS) (data not shown). In summary, these findings strongly suggested that ISVP-like particles containing 1 and 1 accumulated within LAMP-positive compartments (i.e., late endosomes and/or lysosomes) in infections with prcoresϩ1(1-HS).
pr-cores؉1(1-HS) are defective in cellular membrane permeabilization during entry. The behaviors of prcoresϩ1(1-HS) described above consistently suggested that they are defective in membrane penetration during cell entry. As a further test of this conclusion, we assessed the capacity of pr-coresϩ1(1-HS) to mediate cytoplasmic delivery of the ribonucleotoxin ␣-sarcin in trans, a property previously shown to be associated with productive entry by reovirus and rotavirus particles (41, 46) . Inhibition of protein synthesis was used to monitor the extent of ␣-sarcin entry (41) . In control series, incubation of L929 cells with ISVPs alone or ␣-sarcin alone had little effect on protein synthesis, even after 2 h at 37°C (Fig. 9) . However, incubation with ISVPs plus ␣-sarcin led to a shutoff of protein synthesis within 30 to 60 min p.i. at 37°C, consistent with the entry of toxin into the cytoplasm along with penetrating viral particles (Fig. 9) . As expected, prcoresϩ1(1-WT) resembled ISVPs in their capacity to potentiate ␣-sarcin intoxication of cells (Fig. 9) . In contrast, prcoresϩ1(1-HS) caused little increase in cellular intoxication by 2 h p.i. (Fig. 9) , supporting the conclusion that they are defective in membrane penetration during cell entry. 
DISCUSSION
Changes that characterize the ISVP3ISVP* transition in vitro. This article is a follow-up to an earlier report on structural changes in ISVPs that precede membrane permeabilization in vitro (13) . To the published data, we added new in vitro evidence from immunoprecipitations with purified particles, corroborating the conformational change in putative membrane penetration protein 1 and the release of adhesin 1 that accompany the ISVP3ISVP* transition. Immunoprecipitations also revealed an increase in the exposure of core epitopes in ISVP*s. We made use of the core recoating approach (15, 16) to show that particles containing a hyperstable mutant form of 1 exhibit none of the structural and functional changes that characterize the ISVP3ISVP* transition in vitro. The broad in vitro effects of this single type of mutant 1 provided new genetic evidence that 1 plays a key role in the cascade of programmed disassembly events and their functional consequences.
Changes in ISVPs that accompany cell entry. In this study, we demonstrated that features of the ISVP3ISVP* transition in vitro attend cell entry. Structural features included the conformational change in 1, exposure of core epitopes, and shedding of 1. A further structural change, release of the ␦ fragment of 1, is discussed below. Functional features of the ISVP3ISVP* transition-membrane permeabilization and transcriptase activation-were also shown to accompany cell entry. Membrane permeabilization was indicated by the cytoplasmic localization of both particles resembling cores and free ␦ in CHX-treated cells, as well as by cellular intoxication following ␣-sarcin coentry in the absence of CHX. Recent demonstrations of entering particles, resembling cores, being recruited to cytoplasmic inclusions of reovirus nonstructural protein NS have provided further evidence for the cytoplasmic localization of these particles (T. J. Broering, J. Kim, C. L. Miller, M. L. Nibert, and J. S. L. Parker, submitted for publication). Transcriptase activation was indicated by the onset of viral protein synthesis in cells not treated with CHX. As in the in vitro experiments, the consistently "inert" behavior of recoated particles containing hyperstable 1 established a genetic link between the structural and functional changes that accompanied cell entry by particles containing 1-WT.
Hypothesis that ISVP*-like particles are a transient cell entry intermediate. We detected few particles that corresponded directly to ISVP*s inside infected cells. Nevertheless, previous and present findings indicated that ISVP*s are generated and are a necessary entry intermediate (Fig. 10) . (i) FIG. 10 . Updated model for reovirus entry. Whether productive infection by ISVPs can be initiated by penetration at the plasma membrane remains unresolved and is not illustrated here. Wild-type ISVPs and pr-coresϩ1(1-WT) are converted to ISVP*-like particles following cell adhesion and/or uptake. This step is characterized by conformational changes in 1 and 1, release of 1 from viral particles, and derepression of core transcriptases. ISVP*-like particles initiate membrane penetration by inserting viral protein sequences into a cellular lipid bilayer. During or following membrane penetration, protein 1 is removed from ISVP*s by the action of an unknown cellular factor(s), yielding particles that resemble cores. The ␦ fragment of released 1 localizes to the cytoplasm and nucleus. Particles within the cytoplasm initiate viral mRNA synthesis. Unlike their 1-WT-containing counterparts, pr-coresϩ1(1-HS) fail to be converted to ISVP*-like particles, to penetrate the cytoplasm, and to undergo the release of 1. These mutant ISVP-like particles accumulate within late endosomes or lysosomes (LE/LY). EE, early endosomes.
Conversion of ISVPs to cores in vitro, with the attendant disassembly of 1 and 1, must proceed through an ISVP* intermediate (13) . (ii) ISVP*s, but not ISVPs or cores, can permeabilize erythrocyte membranes in vitro (13) . (iii) Recoated particles containing mutant 1 defective in ISVP3ISVP* conversion in vitro undergo intracellular changes in particle structure only at low levels and are defective in membrane penetration and productive cell entry (Fig. 5  to 9 ) (K. Chandran, A. L. Odegard, M. A. Agosto, K. S. Myers, and M. L. Nibert, unpublished data). A probable explanation for the absence of large numbers of ISVP*-like particles in infected cells is that they are quickly converted to a "downstream" particle form, i.e., cores, and therefore do not accumulate (Fig. 10 ) (see below for further discussion). This hypothesis suggests that ISVP3ISVP* conversion is a ratelimiting step in cell entry by wild-type ISVPs.
Accumulation of viral particles in LAMP-positive compartments. In most cells infected with recoated particles containing hyperstable 1, features of the ISVP3ISVP* transition or productive cell entry were not observed, and ISVP-like particles localized extensively to LAMP-positive vacuoles. We postulate that because these particles failed to penetrate from the plasma membrane or an early endocytic compartment, they were passed along the endocytic pathway to later, LAMPcontaining compartments, i.e., late endosomes or lysosomes (11, 44) (Fig. 10) . Alternatively, the particles may normally penetrate from a LAMP-positive vacuole and accumulate there if defective in penetration. Yet another possibility is that one or more of the mutations in hyperstable 1 affects trafficking of the particles to particular subcellular locations. For example, some of the entry-linked structural changes may signal specific trafficking events within cells. Work with other mutant forms of 1 is needed to address these possibilities, but the present study suggests that analysis of the subcellular localization of particles may be a key element in future studies of membrane penetration by reoviruses.
Nature of the 1 conformational change during the ISVP3ISVP* transition. The in vitro immunoprecipitation results identified new reagents for tracking the 1 conformational change both in vitro and in cells. MAbs 4A3 and 10F6 displayed a greater affinity for 1* (in ISVP*s) than for 1 (in ISVPs), whereas MAbs 10H2 and 8H6 bound to the two conformers with similar affinities (Fig. 1) . Immunoblotting and competition ELISA experiments previously indicated that all four MAbs bind to the ␦ region of 1 (residues 43 to 581) and that 4A3, 10H2, and 8H6 specifically bind to the ␤-barrel upper domain (residues 312 to 506) (34, 70) . In contrast, the 10F6 epitope is contained within more C-terminal sequences of ␦ that form part of an ␣-helical "neck" region (residues 507 to 581) (34, 70) . We postulate that 4A3 and 10F6 detect refolding and/or exposure of sequences in the upper parts of the 1 trimer during the 131* change. Such refolded or exposed sequences may participate directly in membrane permeabilization or may form part of a cascade of conformational changes that mobilize membrane-seeking regions from other parts of 1 (see below).
The inert behavior of recoated particles containing hyperstable 1 also provided clues to the nature of the 131* change. 1-HS contains mutations at two positions in the upper domain (residues 319 and 359) that, when separately present in native or recoated particles, confer mildly enhanced thermostability and reduced propensity to undergo the ISVP3ISVP* transition (35, 71; K. S. Myers and M. L. Nibert, unpublished data). Analysis of 1 sequence changes in panels of thermostable viral mutants revealed that many of these changes are located in the ␦ region at intra-or intertrimer interfaces between the upper domains, suggesting that the 131* change involves some degree of trimer dissociation (35, 71 Properties of the ␦ fragment released from entering particles. We observed by IF microscopy that the ␦ fragment of 1 shed from entering particles localized to the cytoplasm and nucleus of cells at early times p.i. (Fig. 1) . Immunoprecipitations of particles from cytoplasmic lysates revealed that a large proportion of ␦ within the lysates remained intact but was indeed no longer particle bound (Fig. 4) . The shed form of ␦ may resemble that in the 1* conformer because it is strongly recognized by MAbs 4A3 and 10F6 (Fig. 1 ). At odds with that hypothesis, however, is the finding that the released form of ␦ is less strongly recognized by MAbs 10H2 and 8H6, which immunoprecipitate similar numbers of ISVPs and ISVP*s in vitro (Fig. 1) . Thus, the released ␦ might represent a novel conformer. To investigate this possibility, we will isolate ␦ from extracts of CHX-treated cells for further analyses. We will also attempt to identify cellular factors that may be involved in the removal and potential refolding of 1 regions during cell entry. A related question is whether any proportion or region of the ␦ fragment is embedded in the lipid bilayer during membrane penetration and, if so, how it may be induced to exit the bilayer to assume the diffusely distributed form seen by IF microscopy. The postentry fates of the 1N and fragments of 1 (51, 53) will also be critical to ascertain.
The accumulation of large amounts of free ␦ within the cytoplasm and nucleus and its persistence for several hours p.i. suggest that this protein may have some postentry function(s) or effect(s). One possibility is that it needs simply to be removed from particles for subsequent steps in replication to proceed efficiently. For example, the removal of ␦ may permit more efficient targeting of the resulting core to a NS inclusion in which RNA synthesis and assembly of new particles can occur (Broering et al., submitted) . Another possibility is that the 1* conformer in entering particles is toxic, perhaps due to its enhanced hydrophobicity (13) , and must be refolded or degraded to prevent cell injury. In fact, several studies have indicated that the M2 genome segment encoding 1 is a genetic determinant of strain differences in virus-induced apoptosis (58, 69) and that the generation of ISVP-like particles, but not viral protein synthesis, is required for apoptosis in some cell lines (19, 21) . Thus, an interesting hypothesis is that a 1 conformer either present in or released from infecting particles may play a positive or negative role in apoptosis. The released 1 protein may also have some postentry function(s) or effect(s), but its predominant localization was not extensively analyzed in this study.
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Membrane penetration mechanism. Passage of large nonenveloped particles across the cellular membrane barrier during entry is commonly thought to require localized disruption of the plasma membrane or lysis of an endocytic compartment (5, 8, 41) . A "reverse budding" model in which particle translocation is mechanistically coupled to disassembly and membrane insertion of viral capsid proteins also has been proposed (66) . Definitive evidence for any mechanism is nonetheless lacking. The capacity of reovirus particles to support the inhibition of cellular protein synthesis by ␣-sarcin (46) (Fig. 9) likely indicates that toxin molecules enter the cytoplasm along with or in the wake of a penetrating viral particle. Similar findings obtained with ␣-sarcin or other toxins have been reported for rotavirus and adenovirus (29, 41, 56) . Because ␣-sarcin is a 17-kDa protein, these findings are consistent with a membrane breach or rupture mechanism for cell entry by these viruses. However, although ␣-sarcin coentry clearly indicates that membrane leakage of such proportion can accompany cell entry, it does not necessarily represent the mechanism by which viral particles productively penetrate the membrane barrier (47) . Isolation and characterization of membrane-associated penetration intermediates may be required to resolve this question.
